Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II studyXiangrui Meng, Feng Wang, Zhiquan Luo et al.|European Journal of Cancer|2024Cited by 18
<sup>68</sup>Ga-FAPI-04 PET/CT Imaging for Assessing Renal Tubulointerstitial Fibrosis in Lupus NephritisShuyi Yu, Min Zhang|Journal of Nuclear Medicine|2025Cited by 15